Nutriband Inc. Common Stock (NTRB)

FairStock Score: 21/100 — RISKY

Key Financials

Strengths

• Conservative balance sheet with debt-to-equity of just 0.03, providing financial flexibility
• Altman Z-Score of 26.0 confirms minimal bankruptcy risk and strong solvency

Concerns

• Revenue declining at 46.4% year-over-year signals potential demand weakness or market share loss
• Weak Piotroski F-Score of 2/9 suggests deteriorating financial quality across multiple dimensions

AI Analysis

Nutriband Inc. Common Stock is a micro-cap healthcare company valued at $50 million. Revenue stands at $2 million. From a quality standpoint, Nutriband shows weak Piotroski F-Score of 2/9 signaling deteriorating fundamentals and Altman Z-Score of 26.0 confirms fortress-level solvency. Growth dynamics show revenue growing at -46.4% and profit growth of -184.2%. Our composite FairStock Score of 21/100 reflects below-average fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.

Bull Case

Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.

Bear Case

Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the healthcare space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer